1-4 of 4
Richard Smith
Close
Sort by
Journal Articles

Inhibiting Very Long Chain Acyl-CoA Dehydrogenase (VLCAD) Induces Selective Leukemia Cell Death

Matthew Tcheng, BSc, Alessia Roma, BSc, Nawaz Ahmed, MSc, Richard Smith, PhD, Preethi Jayanth, PhD, Mark D. Minden, MD PhD, Rose Hurren, BSc, Aaron D Schimmer, MD PhD, Gale Bozzo, PhD, David Hess, PhD, Kristin Hope, PhD, Kevin Rea, MSc, Tariq A. Akhtar, PhD, Al-Walid Mohsen, PhD, Jerry Vockley, MD PhD, Paul A. Spagnuolo, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3922.
https://doi.org/10.1182/blood-2019-122262
Published: 2019
Journal Articles

IDO Pathway Analysis for Identifying Novel Biomarkers in Multiple Myeloma

Vladimir Petrovic, PhD, Jamie Wong, Cedric E. Dos Santos, PhD, Richard Smith, Dan Fitzpatrick, Robert Loberg, Ariel Avilion, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5572.
https://doi.org/10.1182/blood-2018-99-111392
Published: 2018
Journal Articles

Utilization of Metabolomics to Identify Biomarkers in Hematological Malignancies: Role of IDO and the Tryptophan Pathway

Elizabeth Finger, Jamie Wong, Julia Gray, Dan Rock, Robert Loberg, Dan Fitzpatrick, Richard Smith, Xiaozhen Wang, Cedric E. Dos Santos
Journal: Blood
Blood (2017) 130 (Supplement 1): 5100.
https://doi.org/10.1182/blood.V130.Suppl_1.5100.5100
Published: 2017
Journal Articles

Complement factor H mutations are present in ADAMTS13-deficient, ticlopidine-associated thrombotic microangiopathies

John Chapin, Stephen Eyler, Richard Smith, Han-Mou Tsai, Jeffrey Laurence
Journal: Blood
Blood (2013) 121 (19): 4012–4013.
https://doi.org/10.1182/blood-2013-03-487694
Published: 2013